The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Mitochondrial Diseases: Hope for the Future
Open accessAbstract
Mitochondrial diseases are clinically heterogeneous disorders caused by a wide spectrum of mutations in genes encoded by either the nuclear or the mitochondrial genome. Treatments for mitochondrial diseases are currently focused on symptomatic management rather than improving the biochemical defect caused by a particular mutation. This review focuses on the latest advances in the development of treatments for mitochondrial disease, both small molecules and gene therapies, as well as methods to prevent transmission of mitochondrial disease through the germline.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Noe, N., Dillon, L. M., Lellek, V., Díaz, F., Hida, A., Moraes, C. T., & Wenz, T. (2012) · Mitochondrion · doi:10.1016/j.mito.2012.12.003 · Cited by 49
RetractedHow mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Parkin is recruited selectively to impaired mitochondria and promotes their autophagy
Narendra, D., Tanaka, A., Suen, D.-F., & Youle, R. J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200809125 · Cited by 4,026
A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P., & Auwerx, J. (2009) · Nature · doi:10.1038/nature07813 · Cited by 3,300
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy
Twig, G., Elorza, A., Molina, A. J. A., Mohamed, H., Wikstrom, J. D., Walzer, G., Stiles, L., Haigh, S. E., Katz, S., Las, G., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601963 · Cited by 3,082
Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy
Egan, D. F., Shackelford, D. B., Mihaylova, M. M., Gelino, S., Kohnz, R. A., Mair, W., Vasquez, D. S., Joshi, A., Gwinn, D. M., Taylor, R., et al. (2011) · Science · doi:10.1126/science.1196371 · Cited by 2,600
AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α
Jäger, S., Handschin, C., St.-Pierre, J., & Spiegelman, B. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705070104 · Cited by 2,491
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
Mitochondrial DNA mutations in human disease
Taylor, R. W., & Turnbull, D. M. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1606 · Cited by 1,852
Self-citationTranscriptional paradigms in mammalian mitochondrial biogenesis and function
Scarpulla, R. C. (2008) · Physiological Reviews · doi:10.1152/physrev.00025.2007 · Cited by 1,666
Cantó, C., Menzies, K. J., & Auwerx, J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.023 · Cited by 1,648
Gorman, G. S., Chinnery, P. F., DiMauro, S., Hirano, M., Koga, Y., McFarland, R., Suomalainen, A., Thorburn, D. R., Zeviani, M., & Turnbull, D. M. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.80 · Cited by 1,563
Self-citationGomes, A. P., Price, N. L., Ling, A. J. Y., Moslehi, J. J., Montgomery, M. K., Rajman, L., White, J. P., Teodoro, J. S., Wrann, C. D., Hubbard, B. P., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.037 · Cited by 1,482
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation
Halestrap, A. P., & Price, N. T. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3430281 · Cited by 1,348
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
Madiraju, A. K., Erion, D. M., Rahimi, Y., Zhang, X.-M., Braddock, D. T., Albright, R. A., Prigaro, B. J., Wood, J. L., Bhanot, S., MacDonald, M. J., et al. (2014) · Nature · doi:10.1038/nature13270 · Cited by 1,284
Regulation of pgc-1α, a nodal regulator of mitochondrial biogenesis
Fernandez-Marcos, P. J., & Auwerx, J. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.001917 · Cited by 1,237
Corton, J. M., Gillespie, J. G., Hawley, S. A., & Hardie, D. G. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.0558k.x · Cited by 1,230
Targeting Antioxidants to Mitochondria by Conjugation to Lipophilic Cations
Murphy, M. P., & Smith, R. A. J. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105110 · Cited by 1,173
Ryu, D., Mouchiroud, L., Andreux, P. A., Katsyuba, E., Moullan, N., Nicolet-dit-Félix, A. A., Williams, E. G., Jha, P., Lo Sasso, G., Huzard, D., et al. (2016) · Nature Medicine · doi:10.1038/nm.4132 · Cited by 1,105
The dynamics of mitochondrial DNA heteroplasmy: implications for human health and disease
Stewart, J. B., & Chinnery, P. F. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3966 · Cited by 1,031
The emerging role of Nrf2 in mitochondrial function
Dinkova-Kostova, A. T., & Abramov, A. Y. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.04.036 · Cited by 983
Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease
Gorman, G. S., Schaefer, A. M., Ng, Y., Gomez, N., Blakely, E. L., Alston, C. L., Feeney, C., Horvath, R., Yu‐Wai‐Man, P., Chinnery, P. F., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24362 · Cited by 936
Self-citationMitochondria as a therapeutic target for common pathologies
Murphy, M. P., & Hartley, R. C. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.174 · Cited by 827
Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle
Winder, W. W., Holmes, B. F., Rubink, D. S., Jensen, E. B., Chen, M., & Holloszy, J. O. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.6.2219 · Cited by 709
Nuclear activators and coactivators in mammalian mitochondrial biogenesis
Scarpulla, R. C. (2002) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(02)00343-3 · Cited by 631
Basal Mitophagy Occurs Independently of PINK1 in Mouse Tissues of High Metabolic Demand
McWilliams, T. G., Prescott, A. R., Montava-Garriga, L., Ball, G., Singh, F., Barini, E., Muqit, M. M. K., Brooks, S. P., & Ganley, I. G. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.12.008 · Cited by 591
Andreux, P. A., Blanco-Bose, W., Ryu, D., Burdet, F., Ibberson, M., Aebischer, P., Auwerx, J., Singh, A., & Rinsch, C. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0073-4 · Cited by 590
A randomized placebo-controlled trial of idebenone in Leber’s hereditary optic neuropathy.
Klopstock, T., Yu-Wai-Man, P., Dimitriadis, K., Rouleau, J., Heck, S., Bailie, M., Atawan, A., Chattopadhyay, S., Schubert, M., Garip, A., et al. (2011) · Brain · doi:10.1093/brain/awr170 · Cited by 578
Piantadosi, C. A., Carraway, M. S., Babiker, A., & Suliman, H. B. (2008) · Circulation Research · doi:10.1161/01.res.0000338597.71702.ad · Cited by 578
Mitochondrial gene replacement in primate offspring and embryonic stem cells
Tachibana, M., Sparman, M., Sritanaudomchai, H., Ma, H., Clepper, L., Woodward, J., Li, Y., Ramsey, C., Kolotushkina, O., & Mitalipov, S. (2009) · Nature · doi:10.1038/nature08368 · Cited by 573
mtDNA Variation and Analysis Using Mitomap and Mitomaster
Lott, M. T., Leipzig, J. N., Derbeneva, O., Xie, H. M., Chalkia, D., Sarmady, M., Procaccio, V., & Wallace, D. C. (2013) · Current Protocols in Bioinformatics · doi:10.1002/0471250953.bi0123s44 · Cited by 553
Szeto, H. H. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12461 · Cited by 548
mTOR Inhibition Alleviates Mitochondrial Disease in a Mouse Model of Leigh Syndrome
Johnson, S. C., Yanos, M. E., Kayser, E.-B., Quintana, A., Sangesland, M., Castanza, A., Uhde, L., Hui, J., Wall, V. Z., Gagnidze, A., et al. (2013) · Science · doi:10.1126/science.1244360 · Cited by 512
Leigh syndrome: One disorder, more than 75 monogenic causes
Lake, N. J., Compton, A. G., Rahman, S., & Thorburn, D. R. (2016) · Annals of Neurology · doi:10.1002/ana.24551 · Cited by 497
Minimum birth prevalence of mitochondrial respiratory chain disorders in children
Skladal, D. (2003) · Brain · doi:10.1093/brain/awg170 · Cited by 487
Birk, A. V., Liu, S., Soong, Y., Mills, W., Singh, P., Warren, J. D., Seshan, S. V., Pardee, J. D., & Szeto, H. H. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012121216 · Cited by 479
Hypoxia as a therapy for mitochondrial disease
Jain, I. H., Zazzeron, L., Goli, R., Alexa, K., Schatzman-Bone, S., Dhillon, H., Goldberger, O., Peng, J., Shalem, O., Sanjana, N. E., et al. (2016) · Science · doi:10.1126/science.aad9642 · Cited by 438
Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs
Bacman, S. R., Williams, S. L., Pinto, M., Peralta, S., & Moraes, C. T. (2013) · Nature Medicine · doi:10.1038/nm.3261 · Cited by 432
De novo NAD+ synthesis enhances mitochondrial function and improves health
Katsyuba, E., Mottis, A., Zietak, M., De Franco, F., van der Velpen, V., Gariani, K., Ryu, D., Cialabrini, L., Matilainen, O., Liscio, P., et al. (2018) · Nature · doi:10.1038/s41586-018-0645-6 · Cited by 430
Towards germline gene therapy of inherited mitochondrial diseases
Tachibana, M., Amato, P., Sparman, M., Woodward, J., Sanchis, D. M., Ma, H., Gutierrez, N. M., Tippner-Hedges, R., Kang, E., Lee, H.-S., et al. (2013) · Nature · doi:10.1038/nature11647 · Cited by 426
Activators and inhibitors of NRF2: a review of their potential for clinical development
Robledinos-Antón, N., Fernández-Ginés, R., Manda, G., & Cuadrado, A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9372182 · Cited by 413
mTORC1 Regulates Mitochondrial Integrated Stress Response and Mitochondrial Myopathy Progression
Khan, N. A., Nikkanen, J., Yatsuga, S., Jackson, C., Wang, L., Pradhan, S., Kivelä, R., Pessia, A., Velagapudi, V., & Suomalainen, A. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.07.007 · Cited by 387
Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3
Khan, N. A., Auranen, M., Paetau, I., Pirinen, E., Euro, L., Forsström, S., Pasila, L., Velagapudi, V., Carroll, C. J., Auwerx, J., et al. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201403943 · Cited by 385
Mitochondrial and nuclear DNA matching shapes metabolism and healthy ageing
Latorre-Pellicer, A., Moreno-Loshuertos, R., Lechuga-Vieco, A. V., Sánchez-Cabo, F., Torroja, C., Acín-Pérez, R., Calvo, E., Aix, E., González-Guerra, A., Logan, A., et al. (2016) · Nature · doi:10.1038/nature18618 · Cited by 377
Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality
Hudry, E., & Vandenberghe, L. H. (2019) · Neuron · doi:10.1016/j.neuron.2019.02.017 · Cited by 369
Live birth derived from oocyte spindle transfer to prevent mitochondrial disease
Zhang, J., Liu, H., Luo, S., Lu, Z., Chávez-Badiola, A., Liu, Z., Yang, M., Merhi, Z., Silber, S. J., Munné, S., et al. (2017) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2017.01.013 · Cited by 361
Mitochondrial Genome Engineering: The Revolution May Not Be CRISPR-Ized
Gammage, P. A., Moraes, C. T., & Minczuk, M. (2018) · Trends in Genetics · doi:10.1016/j.tig.2017.11.001 · Cited by 344
NAD+-Dependent Activation of Sirt1 Corrects the Phenotype in a Mouse Model of Mitochondrial Disease
Cerutti, R., Pirinen, E., Lamperti, C., Marchet, S., Sauve, A. A., Li, W., Leoni, V., Schon, E. A., Dantzer, F., Auwerx, J., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.04.001 · Cited by 343
Towards clinical application of pronuclear transfer to prevent mitochondrial DNA disease
Hyslop, L. A., Blakeley, P., Craven, L., Richardson, J., Fogarty, N. M. E., Fragouli, E., Lamb, M., Wamaitha, S. E., Prathalingam, N., Zhang, Q., et al. (2016) · Nature · doi:10.1038/nature18303 · Cited by 343
Self-citationParkin overexpression selects against a deleterious mtDNA mutation in heteroplasmic cybrid cells
Suen, D.-F., Narendra, D. P., Tanaka, A., Manfredi, G., & Youle, R. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914569107 · Cited by 337
FGF21 gene therapy as treatment for obesity and insulin resistance
Jimenez, V., Jambrina, C., Casana, E., Sacristan, V., Muñoz, S., Darriba, S., Rodó, J., Mallol, C., Garcia, M., León, X., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708791 · Cited by 324
Genome editing in mitochondria corrects a pathogenic mtDNA mutation in vivo
Gammage, P. A., Viscomi, C., Simard, M.-L., Costa, A. S. H., Gaude, E., Powell, C. A., Van Haute, L., McCann, B. J., Rebelo-Guiomar, P., Cerutti, R., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0165-9 · Cited by 303
Increased mitochondrial mass in mitochondrial myopathy mice
Wredenberg, A., Wibom, R., Wilhelmsson, H., Graff, C., Wiener, H. H., Burden, S. J., Oldfors, A., Westerblad, H., & Larsson, N.-G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232591499 · Cited by 302
In Vivo Correction of COX Deficiency by Activation of the AMPK/PGC-1α Axis
Viscomi, C., Bottani, E., Civiletto, G., Cerutti, R., Moggio, M., Fagiolari, G., Schon, E. A., Lamperti, C., & Zeviani, M. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.04.011 · Cited by 292
Selective Elimination of Mitochondrial Mutations in the Germline by Genome Editing
Reddy, P., Ocampo, A., Suzuki, K., Luo, J., Bacman, S. R., Williams, S. L., Sugawara, A., Okamura, D., Tsunekawa, Y., Wu, J., et al. (2015) · Cell · doi:10.1016/j.cell.2015.03.051 · Cited by 290
Bacman, S. R., Kauppila, J. H. K., Pereira, C. V., Nissanka, N., Miranda, M., Pinto, M., Williams, S. L., Larsson, N.-G., Stewart, J. B., & Moraes, C. T. (2018) · Nature Medicine · doi:10.1038/s41591-018-0166-8 · Cited by 270
Mitochondrial energy generation disorders: genes, mechanisms, and clues to pathology
Frazier, A. E., Thorburn, D. R., & Compton, A. G. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.r117.809194 · Cited by 257
Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids
Taylor, R. W., Chinnery, P. F., Turnbull, D. M., & Lightowlers, R. N. (1997) · Nature Genetics · doi:10.1038/ng0297-212 · Cited by 249
Gene therapy for mitochondrial disease by delivering restriction endonucleaseSmaI into mitochondria
Tanaka, M., Borgeld, H.-J., Zhang, J., Muramatsu, S.-I., Gong, J.-S., Yoneda, M., Maruyama, W., Naoi, M., Ibi, T., Sahashi, K., et al. (2002) · Journal of Biomedical Science · doi:10.1007/bf02254980 · Cited by 232
Clinical Trials in Rare Disease: Challenges and Opportunities
Augustine, E. F., Adams, H. R., & Mink, J. W. (2013) · Journal of Child Neurology · doi:10.1177/0883073813495959 · Cited by 222
Ellouze, S., Augustin, S., Bouaita, A., Bonnet, C., Simonutti, M., Forster, V., Picaud, S., Sahel, J.-A., & Corral-Debrinski, M. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.08.013 · Cited by 222
Cysteamine: an old drug with new potential
Besouw, M., Masereeuw, R., van den Heuvel, L., & Levtchenko, E. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.02.003 · Cited by 221
Modulating NAD + metabolism, from bench to bedside
Katsyuba, E., & Auwerx, J. (2017) · The EMBO Journal · doi:10.15252/embj.201797135 · Cited by 221
Minczuk, M., Papworth, M. A., Miller, J. C., Murphy, M. P., & Klug, A. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn313 · Cited by 214
Aerobic training is safe and improves exercise capacity in patients with mitochondrial myopathy
Jeppesen, T. D., Schwartz, M., Olsen, D. B., Wibrand, F., Krag, T., Duno, M., Hauerslev, S., & Vissing, J. (2006) · Brain · doi:10.1093/brain/awl149 · Cited by 211
Gene Therapy for Leber Hereditary Optic Neuropathy
Guy, J., Feuer, W. J., Davis, J. L., Porciatti, V., Gonzalez, P. J., Koilkonda, R. D., Yuan, H., Hauswirth, W. W., & Lam, B. L. (2017) · Ophthalmology · doi:10.1016/j.ophtha.2017.05.016 · Cited by 204
Schober, P., Bossers, S. M., & Schwarte, L. A. (2018) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002798 · Cited by 201
Mitochondrial Biogenesis as a Pharmacological Target: A New Approach to Acute and Chronic Diseases
Whitaker, R. M., Corum, D., Beeson, C. C., & Schnellmann, R. G. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103155 · Cited by 200
Hashimoto, M., Bacman, S. R., Peralta, S., Falk, M. J., Chomyn, A., Chan, D. C., Williams, S. L., & Moraes, C. T. (2015) · Molecular Therapy · doi:10.1038/mt.2015.126 · Cited by 199
Manipulating mitochondrial DNA heteroplasmy by a mitochondrially targeted restriction endonuclease
Srivastava, S. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.26.3093 · Cited by 187
Peptide nucleic acid delivery to human mitochondria
Chinnery, P. F., Taylor, R. W., Diekert, K., Lill, R., Turnbull, D. M., & Lightowlers, R. N. (1999) · Gene Therapy · doi:10.1038/sj.gt.3301061 · Cited by 178
Self-citationPersistence of the treatment effect of idebenone in Leber’s hereditary optic neuropathy
Klopstock, T., Metz, G., Yu-Wai-Man, P., Büchner, B., Gallenmüller, C., Bailie, M., Nwali, N., Griffiths, P. G., von Livonius, B., Reznicek, L., et al. (2013) · Brain · doi:10.1093/brain/aws279 · Cited by 175
Recent advances in understanding the molecular genetic basis of mitochondrial disease
Thompson, K., Collier, J. J., Glasgow, R. I. C., Robertson, F. M., Pyle, A., Blakely, E. L., Alston, C. L., Oláhová, M., McFarland, R., & Taylor, R. W. (2020) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12104 · Cited by 166
Hypoxia treatment reverses neurodegenerative disease in a mouse model of Leigh syndrome
Ferrari, M., Jain, I. H., Goldberger, O., Rezoagli, E., Thoonen, R., Cheng, K.-H., Sosnovik, D. E., Scherrer-Crosbie, M., Mootha, V. K., & Zapol, W. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621511114 · Cited by 164
An engineered enzyme that targets circulating lactate to alleviate intracellular NADH:NAD+ imbalance
Patgiri, A., Skinner, O. S., Miyazaki, Y., Schleifer, G., Marutani, E., Shah, H., Sharma, R., Goodman, R. P., To, T., Bao, X. R., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-019-0377-7 · Cited by 157
Perales‐Clemente, E., Fernández‐Silva, P., Acín‐Pérez, R., Martos, A. P., & Enríquez, J. A. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq769 · Cited by 156
Lactic acidemia and mitochondrial disease
ROBINSON, B. (2006) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2006.05.015 · Cited by 150
Kauppila, J. H. K., Baines, H. L., Bratić, A. M., Simard, M., Freyer, C., Mourier, A., Stamp, C., Filograna, R., Larsson, N., Greaves, L. C., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.037 · Cited by 149
Phenotypic heterogeneity in m.3243A>G mitochondrial disease: The role of nuclear factors
Pickett, S. J., Grady, J. P., Ng, Y. S., Gorman, G. S., Schaefer, A. M., Wilson, I., Cordell, H. J., Turnbull, D. M., Taylor, R. W., & McFarland, R. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.532 · Cited by 148
Self-citationA Compendium of Genetic Modifiers of Mitochondrial Dysfunction Reveals Intra-organelle Buffering
To, T., Cuadros, A. M., Shah, H., Hung, W. H. W., Yang, L., Kim, S. H., Rubin, D. H. F., Boe, R. H., Rath, S. P., Eaton, J. K., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.032 · Cited by 147
Rare Diseases and Orphan Products: Accelerating Research and Development
Institute of Medicine (2011) · National Academies Press eBooks · doi:10.17226/12953 · Cited by 146
Cell-permeable succinate prodrugs bypass mitochondrial complex I deficiency
Ehinger, J. K., Piel, S., Ford, R., Karlsson, M., Sjövall, F., Frostner, E. Å., Morota, S., Taylor, R. W., Turnbull, D. M., Cornell, C. L., et al. (2016) · Nature Communications · doi:10.1038/ncomms12317 · Cited by 144
Self-citationTargeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs
Yang, Y., Wu, H., Kang, X., Liang, Y., Lan, T., Li, T., Tan, T., Peng, J., Zhang, Q., An, G., et al. (2018) · Protein & Cell · doi:10.1007/s13238-017-0499-y · Cited by 143
Effect of bezafibrate treatment on late-onset mitochondrial myopathy in mice
Yatsuga, S., & Suomalainen, A. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr482 · Cited by 142
Long-term outcomes of gene therapy for the treatment of Leber’s hereditary optic neuropathy
Yang, S., Ma, S.-Q., Wan, X., He, H., Pei, H., Zhao, M.-J., Chen, C., Wang, D.-W., Dong, X.-Y., Yuan, J.-J., et al. (2016) · eBioMedicine · doi:10.1016/j.ebiom.2016.07.002 · Cited by 139
van de Weijer, T., Phielix, E., Bilet, L., Williams, E. G., Ropelle, E. R., Bierwagen, A., Livingstone, R., Nowotny, P., Sparks, L. M., Paglialunga, S., et al. (2015) · Diabetes · doi:10.2337/db14-0667 · Cited by 139
Elamipretide Improves Mitochondrial Function in the Failing Human Heart
Chatfield, K. C., Sparagna, G. C., Chau, S., Phillips, E. K., Ambardekar, A. V., Aftab, M., Mitchell, M. B., Sucharov, C. C., Miyamoto, S. D., & Stauffer, B. L. (2019) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2018.12.005 · Cited by 137
Deoxynucleoside Therapy for Thymidine Kinase 2–Deficient Myopathy
Domínguez‐González, C., Madruga‐Garrido, M., Mavillard, F., Garone, C., Aguirre‐Rodríguez, F. J., Donati, M. A., Kleinsteuber, K., Martí, I., Martín‐Hernández, E., Morealejo‐Aycinena, J. P., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25506 · Cited by 132
Gerards, M., van den Bosch, B. J. C., Danhauser, K., Serre, V., van Weeghel, M., Wanders, R. J. A., Nicolaes, G. A. F., Sluiter, W. J., Schoonderwoerd, K. C., Scholte, H. R., et al. (2010) · Brain · doi:10.1093/brain/awq273 · Cited by 131
Targeting NAD+ Metabolism as Interventions for Mitochondrial Disease
Lee, C. F., Caudal, A., Abell, L., Gowda, G. A. N., & Tian, R. (2019) · Scientific Reports · doi:10.1038/s41598-019-39419-4 · Cited by 129
Jain, I. H., Zazzeron, L., Goldberger, O., Marutani, E., Wojtkiewicz, G. R., Ast, T., Wang, H., Schleifer, G., Степанова, А., Brepoels, K., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.07.006 · Cited by 127
ALEXEYEV, M. F., Venediktova, N. I., Pastukh, V. M., Shokolenko, I. N., Bonilla, G., & Wilson, G. L. (2008) · Gene Therapy · doi:10.1038/gt.2008.11 · Cited by 125
Assisted reproductive technologies to prevent human mitochondrial disease transmission
Greenfield, A., Braude, P., Flinter, F. A., Lovell-Badge, R. H., Ogilvie, C. M., & Perry, A. C. F. (2017) · Nature Biotechnology · doi:10.1038/nbt.3997 · Cited by 125
Civiletto, G., Doğan, Ş. A., Cerutti, R., Fagiolari, G., Moggio, M. G., Lamperti, C., Benincá, C., Viscomi, C. F., & Zeviani, M. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708799 · Cited by 122
Selective removal of deletion-bearing mitochondrial DNA in heteroplasmic Drosophila
Kandul, N. P., Zhang, T., Hay, B. A., & Guo, M. (2016) · Nature Communications · doi:10.1038/ncomms13100 · Cited by 118
Golubitzky, A., Dan, P., Weissman, S., Link, G., Wikström, J. D., & Saada, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026883 · Cited by 114
Nuclear transplantation in mouse embryos
McGrath, J. M., & Solter, D. (1983) · Journal of Experimental Zoology · doi:10.1002/jez.1402280218 · Cited by 113
Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency
Garone, C., García-Díaz, B., Emmanuele, V., López, L. C., Tadesse, S., Akman, H. O., Tanji, K., Quinzii, C. M., & Hirano, M. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404092 · Cited by 110
Increased mitochondrial biogenesis in muscle improves aging phenotypes in the mtDNA mutator mouse
Dillon, L. M., Williams, S. L., Hida, A., Peacock, J. D., Prolla, T. A., Lincoln, J., & Moraes, C. T. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds049 · Cited by 110
Treatment of Mitochondrial Disorders
Avula, S., Parikh, S., Demarest, S., Kurz, J. E., & Gropman, A. L. (2014) · Current Treatment Options in Neurology · doi:10.1007/s11940-014-0292-7 · Cited by 108
Hellebrekers, D. M. E. I., Wolfe, R. S., Hendrickx, A. T. M., de Coo, I. F. M., de Die-Smulders, C. E. M., Geraedts, J. P. M., Chinnery, P. F., & Smeets, H. J. M. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms008 · Cited by 107
Consensus-based statements for the management of mitochondrial stroke-like episodes
Ng, Y. S., Bindoff, L. A., Gorman, G. S., Horváth, R., Klopstock, T., Mancuso, M., Martikainen, M. H., McFarland, R., Nesbitt, V., Pitceathly, R. D. S., et al. (2019) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15599.1 · Cited by 103
Self-citationExercise training in mitochondrial myopathy: A randomized controlled trial
Cejudo, P., Bautista, J., Montemayor, T., Villagómez, R., Jiménez, L., Ruiz, F. Ó., Campos, Y., Sánchez, H., & Arenas, J. (2005) · Muscle & Nerve · doi:10.1002/mus.20368 · Cited by 98
CoQ10 deficiencies and MNGIE: Two treatable mitochondrial disorders
Hirano, M., Garone, C., & Quinzii, C. M. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.01.006 · Cited by 97
Repp, B. M., Mastantuono, E., Alston, C. L., Schiff, M., Haack, T. B., Rötig, A., Ardissone, A., Lombès, A., Catarino, C. B., Diodato, D., et al. (2018) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-018-0784-8 · Cited by 93
mitoTev‐TALE: a monomeric DNA editing enzyme to reduce mutant mitochondrial DNA levels
Pereira, C. V., Bacman, S. R., Arguello, T., Zekonyte, U., Williams, S. L., Edgell, D. R., & Moraes, C. T. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708084 · Cited by 86
Effects of Idebenone on Color Vision in Patients With Leber Hereditary Optic Neuropathy
Rudolph, G., Dimitriadis, K. A., Büchner, B., Heck, S., Al-Tamami, J., Seidensticker, F., Rummey, C., Leinonen, M., Meier, T., & Klopstock, T. (2012) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0b013e318272c643 · Cited by 80
Safety and efficacy of omaveloxolone in patients with mitochondrial myopathy: MOTOR trial
Madsen, K. L., Buch, A. E., Cohen, B. H., Falk, M. J., Goldsberry, A., Goldstein, A. C., Karaa, A., Koenig, M. K., Muraresku, C. C., Meyer, C. J., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000008861 · Cited by 69
Barrow, J. J., Balsa, E., Verdeguer, F., Tavares, C. D. J., Soustek, M. S., Hollingsworth, L. R., Jedrychowski, M. P., Vogel, R. O., Paulo, J. A., Smeitink, J. A. M., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.08.023 · Cited by 64
Towards a therapy for mitochondrial disease: an update
Garone, C., & Viscomi, C. F. (2018) · Biochemical Society Transactions · doi:10.1042/bst20180134 · Cited by 63
Rapamycin in aging and disease: maximizing efficacy while minimizing side effects
Johnson, S. C., & Kaeberlein, M. R. (2016) · Oncotarget · doi:10.18632/oncotarget.10381 · Cited by 62
Parkin modulates heteroplasmy of truncated mtDNA in Caenorhabditis elegans
Valenci, I., Yonai, L., Bar-Yaacov, D., Mishmar, D., & Ben‐Zvi, A. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.11.001 · Cited by 61
Steffann, J., Gigarel, N., Corcos, J., Bonnière, M., Encha‐Razavi, F., Sinico, M., Prevot, S., Dumez, Y., Yamgnane, A., Frydman, R., et al. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2006.048553 · Cited by 56
Bax, B. E., Levene, M., Bain, M. D., Fairbanks, L. D., Filosto, M., Uçar, S. K., Klopstock, T., Kornblum, C., Mandel, H., Rahman, S., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081096 · Cited by 54
Long-Term Bezafibrate Treatment Improves Skin and Spleen Phenotypes of the mtDNA Mutator Mouse
Dillon, L. M., Hida, A., García, S., Prolla, T. A., & Moraes, C. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044335 · Cited by 47
Could Failure in Preimplantation Genetic Diagnosis Justify Editing the Human Embryo Genome?
Steffann, J., Jouannet, P., Bonnefont, J.-P., Chneiweiss, H., & Frydman, N. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.01.004 · Cited by 47
Koene, S., van Bon, L., Bertini, E., Jimenez‐Moreno, C., van der Giessen, L., de Groot, I. J. M., McFarland, R., Parikh, S., Rahman, S., Wood, M., et al. (2018) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-018-0229-5 · Cited by 33
Fatigue in primary genetic mitochondrial disease: No rest for the weary
Parikh, S., Galioto, R., Lapin, B. R., Haas, R., Hirano, M., Koenig, M. K., Saneto, R. P., Zolkipli‐Cunningham, Z., Goldstein, A. C., & Karaa, A. (2019) · Neuromuscular Disorders · doi:10.1016/j.nmd.2019.09.012 · Cited by 32
An antigenomic strategy for treating heteroplasmic mtDNA disorders
Taylor, R. W., Wardell, T. M., Smith, P., Muratovska, A., Murphy, M. P., Turnbull, D. M., & Lightowlers, R. N. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00130-2 · Cited by 31
Self-citationRegulation of mitophagy by the ubiquitin pathway in neurodegenerative diseases
Desai, S. D., Juncker, M. A., & Kim, C. (2018) · Experimental Biology and Medicine · doi:10.1177/1535370217752351 · Cited by 31
Poulton, J., Steffann, J., Burgstaller, J. P., & McFarland, R. (2019) · Neuromuscular Disorders · doi:10.1016/j.nmd.2019.08.004 · Cited by 28
Preliminary Evaluation of Clinician Rated Outcome Measures in Mitochondrial Disease
Newman, J. H., Galna, B., Jakovljević, D. G., Bates, M. G. D., Schaefer, A. M., McFarland, R., Turnbull, D. M., Trenell, M. I., Taylor, R. W., Rochester, L., et al. (2015) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-140061 · Cited by 10
Self-citation
Cited by
Mitochondrial dysfunction: mechanisms and advances in therapy
Zong, Y., Li, H., Liao, P., Chen, L., Pan, Y., Zheng, Y., Zhang, C., Liu, D., Zheng, M., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01839-8 · Cited by 1,172
Borst, P. (2020) · IUBMB Life · doi:10.1002/iub.2367 · Cited by 252
Nakamura, T., Sato, Y., Yamada, Y., Abd Elwakil, M. M., Kimura, S., Younis, M. A., & Harashima, H. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114417 · Cited by 121
Astrocytic Changes in Mitochondrial Oxidative Phosphorylation Protein Levels in Parkinson's Disease
Chen, C., Mossman, E., Malko, P., McDonald, D., Blain, A. P., Bone, L., Erskine, D., Filby, A., Vincent, A. E., Hudson, G., et al. (2022) · Movement Disorders · doi:10.1002/mds.28849 · Cited by 36
Mitochondrial phosphoproteomes are functionally specialized across tissues
Hansen, F. M., Kremer, L. S., Karayel, O., Bludau, I., Larsson, N.-G., Kühl, I., & Mann, M. (2024) · Life Science Alliance · doi:10.26508/lsa.202302147 · Cited by 29
Metadata
- Authors
- Russell, O. M., Gorman, G. S., Lightowlers, R. N., & Turnbull, D. M.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2020-04
- Volume
- 181
- Issue
- 1
- Pages
- 168-188
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W3013061819
- Cited by
- 459
- References
- 126
- FWCI
- 16.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.